Skip to main content
All lobbying clients

BEAM THERAPEUTICS

Lobbying client · Massachusetts · filed 2025 to 2026

Biotech/biopharmaceutical companies

$122,000 Reported spend
9 Filings counted
2 Outside firms hired
3 Bills named

Spend is reported income plus in-house expenses across 9 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 3
  • H.R. 5187
    To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufa…
    2 filings
  • H.R. 7837
    Most Favored Patient Act of 2026
    2 filings
  • H.R. 7871
    MVP Act
    2 filings
 Reported by year 2 years
  • 2026 $20,000 5 filings
  • 2025 $102,000 4 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 4
  • SENATE 4
  • Food & Drug Administration (FDA) 1
 Recent filings 9 total
Q3 report
GRIDIRON PUBLIC AFFAIRS, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 19, 2026
View → Q2 terminationNo activity
AVIVA STRATEGIES (FKA MGB CONSULTING)
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 17, 2026
View → Q2 report
GRIDIRON PUBLIC AFFAIRS, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 16, 2026
View → Registration
GRIDIRON PUBLIC AFFAIRS, LLC
2nd Quarter 2026 (Apr 1 - June 30) · posted May 26, 2026
View → Q1 reportNo activity
AVIVA STRATEGIES (FKA MGB CONSULTING)
1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 17, 2026
View → Q4 report
AVIVA STRATEGIES (FKA MGB CONSULTING)
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $51,000 income · posted Jan 15, 2026
View → Q3 report
AVIVA STRATEGIES (FKA MGB CONSULTING)
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $51,000 income · posted Oct 15, 2025
View → Q2 report
AVIVA STRATEGIES (FKA MGB CONSULTING)
2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 16, 2025
View → Registration
AVIVA STRATEGIES (FKA MGB CONSULTING)
2nd Quarter 2025 (Apr 1 - June 30) · posted Jun 4, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem